Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy.
1977
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literature
1990
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery
1993
Perioperative Management of Antithrombotic Therapy
2012 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Thrombolysis for acute deep vein thrombosis
2004
Prevention of VTE in Nonsurgical Patients
2012 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Executive Summary
2012 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
2005
Iliofemoral Deep Venous Thrombosis: Safety and Efficacy Outcome during 5 Years of Catheter-directed Thrombolytic Therapy
1997
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
A Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents
1998 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Rapid Thrombolysis and Preservation of Valvular Venous Function in High Deep Vein Thrombosis
1979
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Endocrine Therapy of Breast and Prostate Cancer
1989
The pharmacology and clinical uses of tamoxifen
1984
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
1987 StandoutScience
Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial
1986
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
1983
Long-Term Results of Local Thrombolysis Followed by First Rib Resection: An Encouraging Clinical Experience in Treatment of Subclavian Vein Thrombosis
2000
Some peculiarities in the histology of intestinal polyps
1962
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
1981
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Thrombolysis for acute deep vein thrombosis
2016
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
1984
Comparison of Streptokinase with Heparin: Late Results in the Treatment of Deep Venous Thrombosis
1979
Relationship of Polyps of the Colon to Colonic Cancer
1958
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Spontaneous lysis of deep venous thrombi: rate and outcome
1989
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984 Standout
A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial
1979
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Steroid Hormone Receptors in Human Breast Cancer
1983
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Familial hypercholesteremic xanthomatosis: A preliminary report
1959
Predisposing causes of intestinal cancer
1970
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Juvenile polyposis coli.
1966
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis
1978
The evolution of cancer of the colon and rectum
1975 Standout
Tissue Plasminogen Activator (rt-PA) vs Heparin in Deep Vein Thrombosis
1990
Deep Vein Thrombosis Treated With Streptokinase or Heparin
1976
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Deep Vein Thrombosis Treated With Streptokinase or Heparin
1976
Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast
1981 Standout
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis
1984
The surgical dilemma in the primary therapy of invasive breast cancer: A critical appraisal
1970
Works of Charles Eckert being referenced
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial
1980
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
1980
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results
1983
An assessment of radical mastectomy and postoperative irradiation therapy in the treatment of mammary cancer
1964
Polyps of the rectum and colon in children
1957
Biliary tract disease
1956
Adjuvant therapy of stage II breast cancer
1981
Controlled study of thrombolytic therapy in deep vein thrombosis.
1973
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report.
1980